3 Oct 2023Open access
Mucinous tubular and spindle cell carcinoma: A rare kidney tumourPublisher siteUniversitiesAmel Douggaz
Active, last published 2026
In cancer and skin lesions
Amel
Douggaz
Scholar“Research focused on Cancer and Skin Lesions and adjacent fields.”
Claim Your Profile5
H-index
82
Citations
Amel has not officially claimed their profile. If you are Amel, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
mel Douggaz is a researcher working on Cancer and Skin Lesions. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Amel's work has been cited 82 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cancer and Skin Lesions×3Breast Cancer Treatment Studies×2Gallbladder and Bile Duct Disorders×2Breast Lesions and Carcinomas×2Nonmelanoma Skin Cancer Studies×2
04 · Where I am
Affiliations
Affiliation details will appear once this profile is updated.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works1 Mar 2023Open access4cites
Multiple hydatid cyst disease revealed by an expansive intracranial process: A case reportPublisher siteClinical Case Reports, Parasitic infections in humans and animals
14 Jan 2023Open access2cites
Cribriform-morular thyroid carcinoma: A case report with review of the literaturePublisher siteEar Nose & Throat Journal, Genetic factors in colorectal cancer
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Amel?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you